Bausch + Lomb (NYSE:BLCO) has drawn investor attention after recent trading left the shares at a last close of US$16.80, with returns mixed across different periods including the past month and the ...

Bausch + Lomb has partnered with the glaucoma community once again, launching its fifth annual fundraising challenge and sponsoring an awareness campaign in one of its priority therapeutic areas.

Bausch + Lomb Corporation ( (BLCO)) has shared an update. On January 2, 2026, Bausch + Lomb Corporation closed a refinancing of its existing credit facilities by entering into a fourth amendment to ...

Bausch + Lomb is taking out roughly $2.8 billion in new loans to refinance its debt. The eye health company, a subsidy of Bausch Health Cos., said Friday that it was amending its credit agreement to ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today announced that it closed ...

VAUGHAN, Ontario, January 02, 2026--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) ("Bausch + Lomb" or the "company"), a leading global eye health company dedicated to helping people see ...

Bausch + Lomb Corp.’s Rochester manufacturing site is set to play a major role in the company’s contact lens rollout over the next several years. The global eye health company, founded in Rochester, ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will hold an investor day on Thursday, Nov. 13, 2025, at the New ...

Activist investor Jana Partners has built a stake in Cooper COO0.15%increase; green up pointing triangle Cos. and plans to push for strategic alternatives, including a potential deal to combine its ...